IP Library › Granted Patent US 12,544,229
Granted Patent B2
US 12,544,229 · App. 17/626,511 · Granted Feb 10, 2026

Continuous fiber-reinforced build material for additive manufacturing

Inventors: Yulia Kulkova (Turku, FI); Artem Plyusnin (Turku, FI)
Assignee: AMBROCIO OY
A61F2/28A61B17/80A61B17/8071A61F2/2846A61F2/2875A61F2/30965A61L27/42A61L27/44A61L31/121A61L31/125B33Y40/10B33Y70/10B33Y80/00C08J5/243C08J5/244C08J5/245C08J5/246D04C1/06A61B17/842A61L27/54A61L31/16D10B2505/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,229
App. No.
17/626,511
Granted
Feb 10, 2026
Kind
B2
Abstract

A continuous fiber-reinforced build material for additive manufacturing (AM) of fiber-reinforced composite (FRC) structures, a machine for the preparation of the build material, and use of the build material for manufacturing of three-dimensional (3D) FRC end-product devices, such as medical devices for management of musculoskeletal and dental disorders.

Claims (20)

1 . A continuous fiber-reinforced build material for a medical device, comprising at least two continuous multifilament fiber rovings each comprising at least one braided segment having a non-uniformly braided structure, wherein the at least two continuous multifilament rovings are bonded together at intervals through joining points and wherein the build material has an unfolding structure between adjacent joining points creating an umbrella or fishnet structure, and wherein the medical device is for management of musculoskeletal or dental disorders.

2 . The continuous fiber-reinforced build material according to claim 1 , wherein the at least one braided segment of each of the at least two continuous multifilament fiber rovings comprise at least two nested levels of a braided structure.

3 . The continuous fiber-reinforced build material according to claim 1 , wherein the at least two continuous multifilament fiber rovings are bonded together at least partly by weaving, by knitting, by braiding, by stitching, by sintering, via external fixtures, via an adhesive material or by using any combination thereof.

4 . The continuous fiber-reinforced build material according to claim 3 , wherein at least the braided segments of the at least two continuous multifilament fiber rovings are bonded together at least partly by weaving, by knitting, by braiding, by stitching, by sintering, via external fixtures, via an adhesive material or by using any combination thereof.

5 . The continuous fiber-reinforced build material according to claim 1 , comprising matrix material.

6 . The continuous fiber-reinforced build material according to claim 5 , wherein the build material is pre-impregnated with a liquid prepolymer to provide the matrix material.

7 . The continuous fiber-reinforced build material according to claim 5 , wherein at least one of the at least two continuous multifilament fiber rovings comprises fibers of thermoplastic material to provide the matrix material.

8 . The continuous fiber-reinforced build material according to claim 5 , wherein the matrix material is selected from the group consisting of pure polymers, blends of polymers, copolymers, interpenetrating polymer networks, semi-interpenetrating polymer networks, metals, metal alloys, ceramic materials.

9 . The continuous fiber-reinforced build material according to claim 1 , provided in a dry state without matrix material.

10 . The continuous fiber-reinforced build material according to claim 1 , wherein the continuous fiber-reinforced build material is an end-product device.

11 . The continuous fiber-reinforced build material according to claim 10 , wherein the end-product device is a bone plate, a bone screw, an anchor, an intramedullary pin, an orthopaedic wire, a dental disk, a dental implant, a periodontal splint, an orthodontic retainer, a provisional bridge, a dental post, a tooth stump, a cranial implant, a spinal cage, an osteotomy wedge, a device for maxillo-facial reconstruction, a patch or a tape.

12 . The continuous fiber-reinforced build material according to claim 1 , wherein at least one of the at least two multifilament fiber rovings comprises fibers made from glass fibers, carbon fibers, quartz fibers, ceramic fibers, glass-ceramic fibers, metal fibers, synthetic polymer fibers, or semi-synthetic polymer fibers.

13 . The continuous fiber-reinforced build material according to claim 12 , wherein the glass fibers are selected from the group consisting of: fibers of bioactive glass, fibers of S-glass, fibers of R-glass, fibers of D-glass, fibers of C-glass, fibers of E-glass, and fibers of A-glass.

14 . The continuous fiber-reinforced build material according to claim 12 , wherein the fibers made from synthetic polymer fibers or semi-synthetic polymer fibers include fibers made from polyamide or fibers made from polyimide.

15 . The continuous fiber-reinforced build material according to claim 1 , comprising one or more voids.

16 . The continuous fiber-reinforced build material according claim 15 , wherein at least one of said one or more voids comprises autograft, allograft, xenograft, synthetic bone substitute, scaffold for tissue regeneration, active agents and/or musculoskeletal grafts.

17 . The continuous fiber-reinforced build material according to claim 16 , wherein the active agents are selected from the group consisting of: antibiotics; immunosuppressants; immunostimulators; anti-inflammatory agents; osteocalcin; osteoglycin; growth factors; antimicrobial agents; and nanoparticles.

18 . The continuous fiber-reinforced build material according to claim 17 , wherein the growth factors include bone morphogenic proteins, fibroblast growth factors (FGFs), vascular endothelial growth factors (VEGFs), platelet derived growth factors (PDGFs), and transforming growth factors.

19 . The continuous fiber-reinforced build material according to claim 18 , wherein the bone morphogenic proteins include bone morphogenic protein 2 (BMP-2), bone morphogenic protein 4 (BMP-4), bone morphogenic protein 6 (BMP-6), bone morphogenic protein 7 (BMP-7) and bone morphogenic protein 9 (BMP-9).

20 . A continuous fiber-reinforced build material for a medical device, comprising at least two continuous multifilament fiber rovings each comprising at least one braided segment, wherein the at least two continuous multifilament rovings are bonded together at intervals through joining points and wherein the build material has an unfolding structure between adjacent joining points creating an umbrella or fishnet structure, wherein build material comprises a hybrid multifilament fiber roving comprising fibers of different materials, and wherein the medical device is for management of musculoskeletal or dental disorders.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2022
From: KULKOVA, YULIA; PLYUSNIN, ARTEM
To: AMBROCIO OY
Reel/Frame 058626/0174 →
Priority Claims (1)
FI 20195638 · Jul 15, 2019 · national
Continuity (1)
Related Publication 20220259781A1 · Aug 18, 2022
References Cited (23)
US 4664961A · Vees et al. · 1987 [cited by applicant]
US 4917699A · Chervitz · 1990 [cited by applicant]
US 5997970A · You · 1999 [cited by applicant]
US 7419714B1 · Magerl et al. · 2008 [cited by applicant]
US 10287719B2 · Endres et al. · 2019 [cited by applicant]
US 20020130112A1 · Manasas et al. · 2002 [cited by applicant]
US 20050081913A1 · Ebbesen et al. · 2005 [cited by applicant]
US 20070141111A1 · Suokas et al. · 2007 [cited by applicant]
US 20110319978A1 · Schaffer · 2011 [cited by examiner]
US 20120253464A1 · Hwang et al. · 2012 [cited by applicant]
US 20150202430A1 · Finley et al. · 2015 [cited by applicant]
US 20160113695A1 · Globerman et al. · 2016 [cited by applicant]
US 20170273775A1 · Rocco et al. · 2017 [cited by applicant]
US 20190015142A1 · Mitchell · 2019 [cited by examiner]
US 20190127539A1 · Dyksterhouse · 2019 [cited by applicant]
EP 3470097A1 · 2019 [cited by applicant]
WO 9609014A1 · 1996 [cited by applicant]
WO 2019037657A1 · 2019 [cited by applicant]
WO 2019093898A2 · 2019 [cited by applicant]
International Search Report issued by the European Patent Office acting as the International Searching Authority in relation to International Application No. PCT/FI2020/050496 dated Feb. 8, 2021 (7 pages). [cited by applicant]
Written Opinion of the International Searching Authority issued by the European Patent Office acting as the International Searching Authority in relation to International Application No. PCT/FI2020/050496 dated Feb. 8, … [cited by applicant]
Finnish Search Report issued by the Finnish Patent and Registration Office in relation to Finnish Application No. 20195638 dated Nov. 14, 2019 (2 pages). [cited by applicant]
International Preliminary Report on Patentability issued by the European Patent Office acting as the International Prelimianry Examining Authority in relation to International Application No. PCT/FI2020/050496 dated Oct… [cited by applicant]